Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
10.1136/gutjnl-2021-324420
Saved in:
Similar Items
-
ENGINEERING PROBIOTICS TO MODULATE IMMUNE RESPONSES AGAINST BLADDER CARCINOMA
by: SIEOW FU-LONG BRENDAN
Published: (2023) -
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019) -
Targeting immune cells for cancer therapy
by: Gun, Sin Yee, et al.
Published: (2020) -
EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
by: LEONARD WEN YAN LEONG
Published: (2021) -
Targeting immune cells for cancer therapy
by: Gun, S.Y., et al.
Published: (2021)